吉祥坊登录

Prague, Czech Republic—The first implantation of the Minos™ Abdominal Aortic Stent-Graft and Delivery System (“Minos™ Stent Graft System”), a product self-developed by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”), was completed in the Czech Republic. This marks the eleventh overseas market that the Minos™ Stent Graft System has entered, after Greece, Poland, Spain, Germany, Italy, Switzerland, Argentina, Croatia, Hungary and Brazil.

The implantation procedure was performed by a surgical team led by Drs. Pavel Prochazka and Jozef Kučerák from the General Faculty Hospital. Preoperative angiographic examination showed that the patient, a 73-year-old male, had a challenging abdominal aortic aneurysm of approximately 6 cm in diameter, which is complicated by calcification and severe stenosis of the access artery. Considering the aortic stenosis is the most common problem in the EVAR, the team chose the Minos™ Stent Graft System for treatment and performed post-dilation of the branch stent using a balloon. The ultra-low profile delivery sheath of the Minos™ Stent Graft System provides a better solution for patients with complicated abdominal aortic anatomy. Angiography showed that the aneurysm was effectively isolated, the stent graft well conformed to the patient’s anatomy and the blood flow in the branch stent was restored, confirmed the success of the operation.

Drs. Prochazka and Kučerák commented after the procedure, “The Minos™ Stent Graft System features an ultra-low profile delivery sheath that is able to conform to the patient’s narrowed iliac artery. The system provided us a very smooth control experience throughout the procedure. ” 

The Minos™ System features a three-piece design that enables flexible assembly to accommodate different size requirements. Its main body was constructed from a laser-cut M-stent with integrated barbs and covered with seamless woven graft, and its iliac limbs are woven by a single wire in a spiraling pattern. The advanced core technologies are able to meet the treatment needs of a wider range of abdominal aortic aneurysms with complex anatomy, which reduces the rate of complications such as device migration, endoleaks or occlusion, and thus lower the risk of long-term reintervention.

Minos™ Stent Graft System has won the recognition of experts and demonstrated excellent performance in clinical applications in many countries across Europe and South America since it was introduced to the overseas market. With the continuous steps in overseas market, Endovastec™ will further enhance in-depth cooperation with overseas clinical experts, striving to promote more high-quality and innovative solutions for the treatment of aortic and peripheral vascular diseases in overseas markets, so as to benefit more patients worldwide.